Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002132 · ClinicalTrials.gov registry record · NA
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
A NA study of HIV Infections and Candidiasis, Esophageal, sponsored by Janssen Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 18
- Study locations
NCT00002132 is a NA study of HIV Infections and Candidiasis, Esophageal that has completed, run by Janssen Pharmaceuticals. The trial reports 18 study locations across 12 states.
The verdict
NCT00002132, a NA study of HIV Infections and Candidiasis, Esophageal, has completed, sponsored by Janssen Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 18
- Study locations
Study Summary
To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.
Conditions Studied
Interventions
- DRUG Fluconazole
- DRUG Itraconazole
Study Locations (18)
New York
- Erie County Med Ctr - Buffalo
- Dr Douglas Dieterich - New York
- Montefiore Med Ctr - The Bronx
California
- Los Angeles County - USC Med Ctr - Los Angeles
- UCSD Med Ctr - San Diego
Missouri
- Univ of Missouri at Kansas City School of Medicine - Kansas City
- Infectious Diseases Association / Research Med Ctr - Kansas City
North Carolina
- Univ of North Carolina - Chapel Hill
- Bowman Gray School of Medicine - Winston-Salem
Texas
- Austin Infectious Disease Consultants - Austin
- Houston Veterans Administration Med Ctr - Houston
Arizona
- Dr Eskild A Petersen - Tucson
District of Columbia
- George Washington Univ Med Ctr - Washington D.C.
Georgia
- Emory Univ School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002132
The ClinicalTrials.gov registry entry for NCT00002132 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Janssen Pharmaceuticals, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Fluconazole is the first listed.
NCT00002132 reports 18 study locations spanning 12 distinct geographic areas - top geographies include New York, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT00002132 about?
NCT00002132 is a clinical study titled "Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.". To evaluate the safety and efficacy of itraconazole oral solution versus fluconazole tablets for the treatment of esophageal candidiasis in immunocompromised patients.
What is the current status of trial NCT00002132?
This trial is currently completed. It is a NA study.
What conditions does trial NCT00002132 study?
This clinical trial studies the following conditions: HIV Infections, Candidiasis, Esophageal.
What interventions are being tested in trial NCT00002132?
The interventions under investigation include: Fluconazole (DRUG), Itraconazole (DRUG).
Who is sponsoring clinical trial NCT00002132?
This trial is sponsored by Janssen Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002132 being conducted?
This trial has 18 study locations across Arizona, California, District of Columbia, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.